Health
June 6, 2023

FDA Issues Warning Against Modified GLP-1 Drugs: Shortage of Ozempic and Wegovy Triggers Compounded Semaglutide Market

Unapproved and Potentially Unsafe Semaglutide Compounds Flood the Market Amidst Shortage The Food and Drug Administration (FDA) has recently raised concerns over the sale of modified glucagon-like peptide-1 (GLP-1) drugs, particularly semaglutide, prompting a warning to consumers. The United States has been grappling with a shortage of Ozempic and Wegovy, two vital drugs used to […]

Health
June 6, 2023

Exploring the Promise and Limitations of Polygenic Risk Scores in Assessing Heart Disease Risk

Genetic Testing Offers Insights into Personalized Heart Disease Prevention Strategies Medical professionals are constantly seeking innovative approaches to accurately assess a person’s risk of heart disease. While blood tests, CT scans, and electrocardiograms have been conventional methods, a new tool is rapidly gaining popularity: polygenic risk scores. This cutting-edge genetic testing technique analyzes an individual’s […]

Health
June 6, 2023

Oral Estrogen Hormones and High Blood Pressure Risk: New Research Sheds Light on Safer Alternatives

Study published in Hypertension reveals significant findings regarding hormone replacement therapy (HRT) and cardiovascular health According to a recent study published in the peer-reviewed American Heart Association journal, Hypertension, women taking oral estrogen hormones for hormone replacement therapy (HRT) may face a higher risk of developing high blood pressure compared to those using non-oral forms […]